2 Minutes with Joey - PFE Stock News

2 Minutes with Joey - PFE Stock News

2 Minutes with Joey
Country USA
Language EN
Episodes 2
Latest 13.08.2026

A quick daily recap of Pfizer (PFE) stock performance, explaining what the stock did and why in plain English. The podcast is for information and entertainment only, not financial advice.

Episodes

  • PFE Today - Aug 13: CEO Buys Stock
    PFE Today - Aug 13: CEO Buys Stock 13.08.2026 1m
    Hey there! It’s Joey, your friendly stock enthusiast, here to break down what happened with Pfizer today. So, PFE had a pretty solid day, up about 1.5%. Not too shabby, right? Now, let’s get into it. The big news was that Pfizer’s CEO decided to drop a cool million on some company stock. That’s a bold move, and it definitely got some folks talking. When the head honcho puts their money where their mouth is, it usually sends a message. Plus, there’s been buzz around their Lyme disease vaccine showing some impressive numbers—70% efficacy, which is a big deal in the vaccine world. But not everyth...
  • PFE Today - Aug 12: Lagging Stock Performance
    PFE Today - Aug 12: Lagging Stock Performance 12.08.2026 1m
    Hey there! It’s Joey here, your friendly neighborhood investor, breaking down the day for ya. Today, we’re talking about Pfizer, or PFE, and it had a rough go, closing the day in the red, down about 1.3%. Ouch.So, what went down? Well, PFE got smoked today. There’s been a lot of chatter about their stock lagging behind the competition, and it’s pretty clear that investors weren’t feeling it. People hit the sell button fast, and the stock didn’t really bounce back. It’s like everyone’s just waiting for something good to happen, but today was not that day.Now, why did this happen? One big reason...
  • PFE Today - Aug 11: Earnings Decline Sparks Concerns
    PFE Today - Aug 11: Earnings Decline Sparks Concerns 11.08.2026 1m
    Hey there! It’s Joey, your friendly neighborhood investor. Today, we’re talking about Pfizer, and it was a red day for them. The stock dipped about half a percent. Ouch!So here’s the scoop. Pfizer’s been on a bit of a rollercoaster lately. Today’s drop follows a pretty rough earnings report where they revealed their earnings have tanked by 58% this year. Yeah, that one stung. Investors are getting a little jittery, wondering if a dividend cut might be on the way. Nobody likes to hear that, especially if you’re counting on those payouts.Now, why did this happen? Well, analysts are buzzing after...
  • PFE Today - Aug 10: Strong Q2 Results Boost Stock
    PFE Today - Aug 10: Strong Q2 Results Boost Stock 10.08.2026 1m
    Hey there! It's Joey here, your friendly neighborhood investor, breaking down the day’s action. Today we're chatting about Pfizer, and it was a green day for them! The stock was up a little over a third of a percent. Not huge, but hey, green is good, right?So, what happened? Pfizer's been riding a bit of a wave after dropping their Q2 results. They jumped almost 7% right after those numbers came out. Pretty solid response! But today, it looks like the excitement simmered down a bit, and they just kinda floated along. You know how it is—sometimes the hype just cools off.Now, why did the stock m...
  • PFE Today - Aug 09: Pfizer's Earnings Beat Sparks Interest
    PFE Today - Aug 09: Pfizer's Earnings Beat Sparks Interest 09.08.2026 1m
    Hey, what’s up? It’s Joey here, your friendly investor buddy, breaking down the day for you. Today we’re talking about Pfizer, and guess what? It had a pretty solid green day, up about 2%. So, here’s the scoop. Pfizer's stock caught some good vibes today, moving higher after they reported their earnings. They actually beat the estimates, which is always a nice surprise, right? And they’re eyeing some serious cost cuts, targeting around $2.5 billion. That’s a big chunk of change! People seemed to like the sound of that, so they were hitting the buy button. Now, let’s talk about why this is happ...
  • PFE Today - Aug 08: Pfizer's Lyme Vaccine Shines
    PFE Today - Aug 08: Pfizer's Lyme Vaccine Shines 08.08.2026 1m
    Hey there! It’s Joey, your friendly stock guy, and I’ve been in the investing game for a while now. Today, we’re talking about Pfizer, and it was a green day – nice to see that 2.06% bump!So, what went down? Pfizer’s stock got a little boost today, moving up a bit, and you know what? It actually outperformed some of its competitors. That's always a nice surprise. Traders were definitely feeling a bit more optimistic about it today.Now, the big news fueling that little jump? It’s all about Pfizer’s Lyme disease vaccine showing some solid results with a 70% efficacy rate. That’s a huge deal, esp...
  • PFE Today - Aug 07: Earnings Beat, Stock Slips
    PFE Today - Aug 07: Earnings Beat, Stock Slips 07.08.2026 1m
    Hey there! It’s Joey, your friendly longtime investor, here to break down the day. Today we’re talking about Pfizer, and it was a red day for them. The stock slipped about three-quarters of a percent. So, what went down? Pfizer’s earnings report was actually pretty solid. They beat expectations, which usually gets folks hyped, but today, that wasn’t enough. The stock got hit, even with their announcement of some hefty cost cuts—like $2.5 billion worth. That’s a big number, but it seems like investors weren’t feeling it. There was also some mixed news about their cancer drug from Seagen that di...
  • PFE Today - Aug 06: Earnings Beat, Stock Still Slips
    PFE Today - Aug 06: Earnings Beat, Stock Still Slips 06.08.2026 1m
    Hey there! It’s Joey here, your friendly neighborhood investor, breaking down what went down with Pfizer today. So, PFE had a bit of a red day, barely up at 0.62%. Now, here’s the scoop. Pfizer’s been all over the place lately. They reported earnings that actually beat expectations, which usually gives stocks a nice little boost, right? But instead of soaring, it kinda just hung around. People were hitting the sell button, probably because they saw some big red flags. One of their COVID drugs saw revenue drop a whopping 95%. Yeah, that one stung. Despite the earnings beat, there were some conc...
  • PFE Today - Aug 05: Covid Pill Revenue Plummets
    PFE Today - Aug 05: Covid Pill Revenue Plummets 05.08.2026 1m
    Hey there! I'm Joey, your friendly neighborhood investor. Today, we’re talking about Pfizer, and it was a bit of a rough ride—down just a smidge, like barely 0.04%. Not a huge drop, but still, a red day.So, what went down? Pfizer's stock didn’t really move much, even though there was a big story about their Covid pill revenue crashing—like, down 95%. Ouch. But here’s the kicker: despite that massive drop, the stock was still kind of holding its ground. It’s like everyone was shrugging and saying, “Yeah, that stung, but we’ve got other stuff going on.”Now, why did it manage to stay afloat? Well...
  • PFE Today - Aug 04: Covid Pill Revenue Plunges
    PFE Today - Aug 04: Covid Pill Revenue Plunges 04.08.2026 1m
    Hey, what’s up? It’s Joey here, your friendly stock guy, and I’ve been investing for a minute. Today we’re talking about Pfizer, and it was a bit of a red day for them, down about half a percent. Not the end of the world, but yeah, it wasn’t great.So, what went down? Pfizer’s stock kinda got smoked today, mainly because their Covid pill revenue took a massive hit—like, a 95% drop. Ouch! That’s a big deal, right? But here’s the kicker: even with that bad news, Pfizer still managed to raise its revenue guidance for the year. They bumped it up by $500 million. Talk about mixed signals! Investors...
  • PFE Today - Aug 03: Lyme Vaccine Shows Promise
    PFE Today - Aug 03: Lyme Vaccine Shows Promise 03.08.2026 1m
    Hey there! It's Joey, your friendly longtime investor, here to break down the day for Pfizer. So, PFE had a bit of a chill day, barely moving, just up a tiny bit—like 0.34%. What happened? Well, the stock didn’t really make any big moves today. It was kind of a slow bleed, you know? Nothing too dramatic on the charts. But here’s what’s interesting—Pfizer’s Lyme disease vaccine showed some solid numbers, hitting 70% efficacy. That’s a big deal in the vaccine world! Now, why did the stock act like it was on cruise control? A few things played into it. First, there’s excitement about that Lyme va...
  • PFE Today - Aug 02: Slight Gain Before Earnings
    PFE Today - Aug 02: Slight Gain Before Earnings 02.08.2026 1m
    Hey there! It’s Joey, your friendly investor buddy, breaking down the day for you. Today, we’re chatting about Pfizer — and guess what? It was a green day! The stock ticked up about 0.4%. Not a huge jump, but hey, it’s better than getting smoked.So, what went down? Pfizer’s stock kinda just floated up a bit. There was a lot of buzz around the company as folks are gearing up for their Q2 earnings report. They’ve got this weight loss drug in late-stage trials that’s got some potential, which is pretty exciting. Plus, some chatter around their drug Eliquis seems to be giving them a nice boost too...
  • PFE Today - Aug 01: Mixed Signals Ahead
    PFE Today - Aug 01: Mixed Signals Ahead 01.08.2026 1m
    Hey there! It’s Joey, your go-to guy for stock chatter. I’ve been in this game for years, and today we’re looking at Pfizer, or PFE, and guess what? It was a bit of a slow day, barely up 0.4%. Not exactly fireworks, right? So, here’s the scoop. Pfizer’s stock kinda floated around today, not too much movement. It opened, did its thing, and closed right around $25.01. Volume was pretty steady, just like it usually is. Nothing wild on that front. Now, why did it move the way it did? Well, some folks were pretty pumped about their Lyme disease vaccine showing a solid 70% efficacy. That definitely...
  • PFE Today - Jul 31: Lyme Vaccine News
    PFE Today - Jul 31: Lyme Vaccine News 31.07.2026 1m
    Hey there! It’s Joey here, your friendly neighborhood investor. Today, I’m breaking down Pfizer, or PFE as we like to call it. It was a bit of a flat day, down just a smidge, like 0.3%. Not a huge deal, but still a red day.So, what went down? Well, the stock didn’t really budge much, hanging around that $24.83 mark. It’s like it was just chillin’ there, not making any big moves. Volume was steady, so no wild swings today. Now, let’s chat about why it played out this way. There’s some buzz around Pfizer’s Lyme disease vaccine, which is showing some promising results with 70% efficacy. That’s pr...
  • PFE Today - Jul 30: Earnings Ahead, Stock Slips
    PFE Today - Jul 30: Earnings Ahead, Stock Slips 30.07.2026 1m
    Hey there! It’s Joey here, your friendly longtime investor, breaking down the day for you. Today, we’re talking about Pfizer, and it was a red day for them, down about 2.25%. Ouch!So, what went down? Well, PFE got smoked today, slipping in price and leaving some folks scratching their heads. The stock was pretty steady for a bit but then just couldn’t hold onto its gains. Now, why did this happen? There’s a lot of chatter about Pfizer's upcoming Q2 earnings report. People are wondering if the numbers will impress or disappoint. Some analysts think the stock's looking fairly valued, but there’s...
  • PFE Today - Jul 29: Weaker Earnings, Strong Pipeline
    PFE Today - Jul 29: Weaker Earnings, Strong Pipeline 29.07.2026 1m
    Hey there! It’s Joey, your friendly stock buddy, and I’ve been in the investing game for years. Today, let’s talk about Pfizer, or PFE if you’re into the tickers. It was a pretty chill day for the stock—barely moved, just hanging out at the same price.So, what went down? The stock didn’t really budge, like it was stuck in neutral. Volume was steady but nothing crazy. It’s like the market was waiting for something to happen, but today, it was just a slow day for PFE.Now, why the stall? Well, there’s a lot of chatter about Pfizer’s pipeline. They’ve got some solid stuff coming down the line, whi...
  • PFE Today - Jul 28: Earnings Buzz and Dividend Talk
    PFE Today - Jul 28: Earnings Buzz and Dividend Talk 28.07.2026 1m
    Hey there! It’s Joey, your friendly longtime investor, here to break down the day. Today we’re chatting about Pfizer, and guess what? It was a green day, up about 2.9%. Not too shabby!So, what went down? Pfizer’s stock got a nice little boost, and it seems like folks are feeling a bit more optimistic. There’s a buzz around their upcoming earnings report, which is always a big deal. Plus, the chatter about their 7% dividend is getting some attention, especially with people looking closely at cash flow. Seems like investors are trying to figure out if that dividend is solid or if they need to wo...
  • PFE Today - Jul 27: FDA Review Sparks Interest
    PFE Today - Jul 27: FDA Review Sparks Interest 27.07.2026 1m
    Hey there! It’s Joey here, your friendly stock enthusiast, and I've been in the investing game for years. Today, we're talking about Pfizer, and it was a bit of a green day for them, up just a smidge by about 0.81%. So, what happened? Well, the stock saw some movement, but nothing wild. It was mostly stable, hanging around that $24.74 mark. There was some buzz in the air, though, thanks to the FDA giving a priority review for one of Pfizer's drugs aimed at prostate cancer. That got people chatting and maybe even a little excited.Now, why did Pfizer see this slight uptick? The big news is that...
  • PFE Today - Jul 26: Lung Cancer Trial Disappointment
    PFE Today - Jul 26: Lung Cancer Trial Disappointment 26.07.2026 1m
    Hey, what’s up? It’s Joey here, your friendly investor buddy. Just breaking down the day for you. Today, we're talking about Pfizer, and it was a red day—down about 1.9%. Ouch!So here’s the scoop. Pfizer's stock took a hit today, and honestly, it got smoked. The main reason? They had some disappointing news from a lung cancer trial. Investors were expecting big things, but when the results came in, it was more of a letdown. You know how it goes—people hit the sell button fast when things don’t look good. Now, while the lung cancer news was a bummer, there was also some chatter about Ibrance, w...
  • PFE Today - Jul 25: Lung Cancer Trial Disappointment
    PFE Today - Jul 25: Lung Cancer Trial Disappointment 25.07.2026 1m
    Hey there! It’s Joey, your friendly neighborhood investor, and I’m here to break down what went down with Pfizer today. So, PFE had a rough day, dropping about 1.9%. Yeah, that one stung.Here’s the scoop: Pfizer’s stock got smoked because of some disappointing news from a lung cancer trial. Investors were really hoping for a win there, but it didn’t pan out, and that sent people racing for the exits. The market didn’t like it at all. On top of that, there was some buzz around their dividend yield looking pretty solid, but honestly, that wasn’t enough to stop the bleeding today.Now, why did the...

Popular in

The podcast also appears in the podcast charts of these countries.